The scale of the challenge posed to pharmaceutical companies by generic drug manufacturers was underlined yesterday when AstraZeneca announced a 16% drop in third-quarter pre-tax profit, and another of its products faced copycat competition.
Link to Article
Additional Story
AstraZeneca faces patent battle on No 3 drug as profits tumble - The Times 2nd November 2007
The scale of the challenge posed to pharmaceutical companies by generic drug manufacturers was underlined yesterday when AstraZeneca announced a 16%
Friday, November 02, 2007
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment